HDEF - AI Analysis

Compare

Top Page

Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)

Rating:67Neutral

Price Target:

$32.00

The ETF HDEF has a solid overall rating, driven by strong contributions from holdings like Novartis AG and Shell. Novartis benefits from robust profitability, effective cash flow management, and strategic initiatives, while Shell adds stability with its attractive valuation and high dividend yield. However, weaker holdings like British American Tobacco, with bearish technical indicators and valuation concerns, slightly hold back the fund’s rating. A key risk factor is the ETF's concentration in a few sectors, which could limit diversification.

Positive Factors

Strong Top Holdings

Several of the largest positions, such as Roche Holding AG and Iberdrola, have delivered strong year-to-date performance, supporting the ETF's overall returns.

Low Expense Ratio

The ETF charges a very low expense ratio, making it a cost-effective choice for investors.

Geographic Diversification

The fund is spread across multiple countries, including the UK, Switzerland, and Japan, reducing reliance on any single economy.

Negative Factors

Sector Concentration in Financials

The ETF has a high allocation to the financial sector, which could make it vulnerable to downturns in that industry.

Underperforming Holding

TotalEnergies SE, one of the top 10 holdings, has shown negative year-to-date performance, which may drag on the fund's overall returns.

Limited U.S. Exposure

With only 1.12% allocated to U.S. companies, the fund may miss out on growth opportunities in the world's largest economy.

HDEF vs. SPDR S&P 500 ETF (SPY)

AUM2.14B

RegionDeveloped Markets

Expense Ratio0.09%

Beta0.46

IssuerXtrackers

Inception DateAug 12, 2015

Dividend Yield3.92%

Asset ClassEquity

Index TrackedMSCI EAFE High Dividend Yield

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume92,905

30 Day Avg. Volume119,003

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

31.80

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering114

HDEF Summary

The Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF) is an investment fund that focuses on companies outside the U.S. and Canada, specifically in developed markets like Europe, Japan, and Australia. It follows the MSCI EAFE High Dividend Yield Index, which includes established companies known for paying high dividends. Some of its top holdings include well-known names like Novartis and Shell. This ETF is ideal for investors looking to diversify globally while earning steady income through dividends. However, since it focuses on international markets, its performance can be affected by global economic conditions and currency fluctuations.

How much will it cost me?The expense ratio for HDEF is 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because HDEF is passively managed, tracking an index rather than relying on active stock selection.

What would affect this ETF?HDEF could benefit from stable dividend payouts and growth in developed markets outside North America, especially if sectors like financials and healthcare, which have significant weight in the ETF, perform well. However, challenges such as rising interest rates, economic slowdowns in Europe or Asia, or regulatory changes affecting top holdings like Novartis or Shell could negatively impact returns. Diversification across sectors and regions provides some resilience, but global economic conditions remain a key factor to watch.

HDEF Top 10 Holdings

The Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF) leans heavily on developed markets outside North America, with a strong focus on financials, consumer defensive, and healthcare sectors. European giants like Novartis and Roche are steady performers, buoyed by robust pipelines and solid cash flow management. Energy names like Shell and TotalEnergies have seen mixed results, with Shell holding steady while TotalEnergies faces challenges in cash flow. Meanwhile, British American Tobacco is lagging, weighed down by bearish technical trends despite its attractive dividend yield. Overall, the fund’s sector concentration in financials and consumer staples provides stability, but energy and tobacco stocks may temper its momentum.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
SHEL	Shell (UK)	5.31%	$112.69M	£165.60B	15.46%	77 Outperform
NOVN	Novartis AG	5.18%	$109.91M	CHF187.47B	3.30%	78 Outperform
ALV	Allianz	4.89%	$103.68M	€136.21B	21.06%	74 Outperform
ROG	Roche Holding AG	4.85%	$102.91M	CHF208.68B	3.85%	73 Outperform
ULVR	Unilever	4.47%	$94.84M	£113.03B	-2.84%	77 Outperform
IBE	Iberdrola	4.00%	$84.80M	€116.41B	27.42%	67 Neutral
TTE	TotalEnergies SE	3.96%	$84.09M	€116.79B	-16.61%	71 Outperform
SAN	Sanofi	3.47%	$73.58M	€107.19B	-3.86%	77 Outperform
BATS	British American Tobacco	3.31%	$70.30M	£85.35B	48.04%	60 Neutral
ZURN	Zurich Insurance Group	3.19%	$67.73M	CHF80.67B	21.46%	80 Outperform

HDEF Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price―

Price Trends

50DMA

29.59

Negative

100DMA

29.18

Positive

200DMA

27.68

Positive

Market Momentum

MACD

0.07

Positive

RSI

48.35

Neutral

STOCH

37.42

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 29.67, equal to the 50-day MA of 29.59, and equal to the 200-day MA of 27.68, indicating a neutral trend. The MACD of 0.07 indicates Positive momentum. The RSI at 48.35 is Neutral, neither overbought nor oversold. The STOCH value of 37.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HDEF.

HDEF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
HDEF	―	―	$2.14B	0.09%	67 Neutral
FDVV	―	―	$7.38B	0.16%	72 Outperform
IDV	―	―	$6.03B	0.50%	57 Neutral
DIVI	―	―	$1.91B	0.09%	64 Neutral
DTH	―	―	$493.20M	0.58%	62 Neutral
EFAS	―	―	$33.25M	0.56%	55 Neutral

Performance Comparison

HDEF

Xtrackers MSCI EAFE High Dividend Yield Equity ETF

29.59

5.01

20.38%

FDVV

Fidelity High Dividend ETF

―

IDV

iShares International Select Dividend ETF

―

DIVI

Franklin LibertyQ International Equity Hedged ETF

―

DTH

WisdomTree International High Dividend Fund

―

EFAS

Global X MSCI SuperDividend EAFE ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents